nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—AGTR1—nephron—nephrolithiasis	0.0838	0.365	CbGeAlD
Eprosartan—Losartan—SLC2A9—nephrolithiasis	0.0355	0.54	CrCbGaD
Eprosartan—CYP2C9—urine—nephrolithiasis	0.0324	0.141	CbGeAlD
Eprosartan—Losartan—SLC22A12—nephrolithiasis	0.0302	0.46	CrCbGaD
Eprosartan—Toothache—Hydrochlorothiazide—nephrolithiasis	0.0223	0.0316	CcSEcCtD
Eprosartan—Serum creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.022	0.0313	CcSEcCtD
Eprosartan—AGTR1—nephron tubule—nephrolithiasis	0.0181	0.0788	CbGeAlD
Eprosartan—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0238	CcSEcCtD
Eprosartan—AGTR1—renal system—nephrolithiasis	0.0165	0.0716	CbGeAlD
Eprosartan—AGTR1—kidney—nephrolithiasis	0.0159	0.0692	CbGeAlD
Eprosartan—AGTR1—cortex of kidney—nephrolithiasis	0.0155	0.0674	CbGeAlD
Eprosartan—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0218	CcSEcCtD
Eprosartan—Gout—Hydrochlorothiazide—nephrolithiasis	0.0145	0.0206	CcSEcCtD
Eprosartan—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0143	0.0204	CcSEcCtD
Eprosartan—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0201	CcSEcCtD
Eprosartan—ABCC2—nephron tubule—nephrolithiasis	0.0131	0.0569	CbGeAlD
Eprosartan—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0176	CcSEcCtD
Eprosartan—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0174	CcSEcCtD
Eprosartan—ABCC2—renal system—nephrolithiasis	0.0119	0.0518	CbGeAlD
Eprosartan—ABCC2—kidney—nephrolithiasis	0.0115	0.05	CbGeAlD
Eprosartan—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0161	CcSEcCtD
Eprosartan—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0159	CcSEcCtD
Eprosartan—ABCC2—cortex of kidney—nephrolithiasis	0.0112	0.0487	CbGeAlD
Eprosartan—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0158	CcSEcCtD
Eprosartan—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0158	CcSEcCtD
Eprosartan—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.011	0.0156	CcSEcCtD
Eprosartan—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0149	CcSEcCtD
Eprosartan—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0148	CcSEcCtD
Eprosartan—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0147	CcSEcCtD
Eprosartan—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0145	CcSEcCtD
Eprosartan—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0144	CcSEcCtD
Eprosartan—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00988	0.014	CcSEcCtD
Eprosartan—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00969	0.0138	CcSEcCtD
Eprosartan—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0095	0.0135	CcSEcCtD
Eprosartan—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00926	0.0131	CcSEcCtD
Eprosartan—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00922	0.0131	CcSEcCtD
Eprosartan—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00899	0.0128	CcSEcCtD
Eprosartan—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00896	0.0127	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00886	0.0126	CcSEcCtD
Eprosartan—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00871	0.0124	CcSEcCtD
Eprosartan—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00868	0.0123	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00868	0.0123	CcSEcCtD
Eprosartan—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00829	0.0118	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00791	0.0112	CcSEcCtD
Eprosartan—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00786	0.0112	CcSEcCtD
Eprosartan—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00767	0.0109	CcSEcCtD
Eprosartan—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00746	0.0106	CcSEcCtD
Eprosartan—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00744	0.0106	CcSEcCtD
Eprosartan—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00737	0.0105	CcSEcCtD
Eprosartan—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00737	0.0105	CcSEcCtD
Eprosartan—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00723	0.0103	CcSEcCtD
Eprosartan—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00715	0.0102	CcSEcCtD
Eprosartan—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00712	0.0101	CcSEcCtD
Eprosartan—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00693	0.00984	CcSEcCtD
Eprosartan—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00683	0.00969	CcSEcCtD
Eprosartan—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00676	0.00959	CcSEcCtD
Eprosartan—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00671	0.00952	CcSEcCtD
Eprosartan—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00656	0.00932	CcSEcCtD
Eprosartan—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00635	0.00901	CcSEcCtD
Eprosartan—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00584	0.00829	CcSEcCtD
Eprosartan—Tension—Hydrochlorothiazide—nephrolithiasis	0.00582	0.00826	CcSEcCtD
Eprosartan—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00576	0.00817	CcSEcCtD
Eprosartan—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00573	0.00814	CcSEcCtD
Eprosartan—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0057	0.00809	CcSEcCtD
Eprosartan—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00555	0.00788	CcSEcCtD
Eprosartan—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0055	0.00781	CcSEcCtD
Eprosartan—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00542	0.00769	CcSEcCtD
Eprosartan—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00535	0.00759	CcSEcCtD
Eprosartan—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00533	0.00756	CcSEcCtD
Eprosartan—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00532	0.00755	CcSEcCtD
Eprosartan—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00744	CcSEcCtD
Eprosartan—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00521	0.0074	CcSEcCtD
Eprosartan—Cough—Hydrochlorothiazide—nephrolithiasis	0.00517	0.00734	CcSEcCtD
Eprosartan—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00505	0.00716	CcSEcCtD
Eprosartan—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00505	0.00716	CcSEcCtD
Eprosartan—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00505	0.00716	CcSEcCtD
Eprosartan—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00503	0.00714	CcSEcCtD
Eprosartan—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00499	0.00708	CcSEcCtD
Eprosartan—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00494	0.00701	CcSEcCtD
Eprosartan—Shock—Hydrochlorothiazide—nephrolithiasis	0.00476	0.00676	CcSEcCtD
Eprosartan—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00474	0.00672	CcSEcCtD
Eprosartan—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00472	0.0067	CcSEcCtD
Eprosartan—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00468	0.00664	CcSEcCtD
Eprosartan—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00461	0.00655	CcSEcCtD
Eprosartan—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00642	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00441	0.00626	CcSEcCtD
Eprosartan—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00438	0.00621	CcSEcCtD
Eprosartan—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00434	0.00617	CcSEcCtD
Eprosartan—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00612	CcSEcCtD
Eprosartan—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0043	0.00611	CcSEcCtD
Eprosartan—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00426	0.00605	CcSEcCtD
Eprosartan—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00421	0.00597	CcSEcCtD
Eprosartan—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00417	0.00592	CcSEcCtD
Eprosartan—Pain—Hydrochlorothiazide—nephrolithiasis	0.00414	0.00587	CcSEcCtD
Eprosartan—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00414	0.00587	CcSEcCtD
Eprosartan—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00399	0.00566	CcSEcCtD
Eprosartan—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00396	0.00562	CcSEcCtD
Eprosartan—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00384	0.00546	CcSEcCtD
Eprosartan—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00543	CcSEcCtD
Eprosartan—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00543	CcSEcCtD
Eprosartan—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00356	0.00506	CcSEcCtD
Eprosartan—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00347	0.00493	CcSEcCtD
Eprosartan—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00486	CcSEcCtD
Eprosartan—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00331	0.0047	CcSEcCtD
Eprosartan—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0032	0.00454	CcSEcCtD
Eprosartan—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00308	0.00437	CcSEcCtD
Eprosartan—Rash—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00433	CcSEcCtD
Eprosartan—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00433	CcSEcCtD
Eprosartan—Headache—Hydrochlorothiazide—nephrolithiasis	0.00303	0.0043	CcSEcCtD
Eprosartan—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00287	0.00408	CcSEcCtD
